Strategic Z-Morh and Zojila tunnels in Kashmir to be completed ahead of schedule say NHIDCL officials

While the 6.5-km Z-Morh tunnel is expected to be completed by next year, ahead of the target date of December 2023, the 14.15 km Zojila tunnel is also scheduled to be completed ahead of the target date of 2026, NHIDCL officials said.

Yaruqhullah Khan

September 28, 2021 / 10:53 AM IST

Z-Morh Tunnel, Main Tunnel on the left, Escape Tube on the right

As part of the strategic projects for ensuring round-the-year connectivity between Kashmir valley and Ladakh region, work on the Z-Morh Tunnel Project and Zojila Tunnel Project is going ahead of schedule and is likely to be completed before time, officials from the National Highway Infrastructure Development Corp (NHIDCL) said.

While the 6.5-km Z-Morh tunnel is expected to be completed by next year, ahead of the target date of December 2023, the 14.15 km Zojila tunnel is also scheduled to be completed ahead of the target date of 2026, NHIDCL officials said.

Both the tunnels are quite significant in nature and will help to keep the Union Territory (UT) of Ladakh connected for the whole year with the rest of the country. The tunnels will also boost the Tourism Sector of both the UTs and keep the hassle-free movement of the armed forces during any weather conditions.

Zojila Pass is the strategic link connecting the Leh-Ladakh region to Srinagar in Jammu & Kashmir, and with the rest of India. The region however does not have all-weather connectivity, especially to Leh, the capital of the Union Territory of Ladakh. This has adversely impacted the transport sector, thereby affecting the economy of the region.

Z-Morh Tunnel

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show